The results indicate that 10 μg/per day of EB1089 acted as a key chemoprevention agent, and its anti-cancer properties were related to antiproliferative, pro-differentiating, and gene-protective effects through the induction of GADD45α. This evidence concerns the gene GADD45A and cancer.